Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience

Avin Aggarwal, Eric R. Yoo, Ryan B. Perumpail, George Cholankeril, Radhika Kumari, Tami Daugherty, Alex S. Lapasaran, Aijaz Ahmed

Journal of Clinical and Translational Hepatology · 2017 · 15 citations · 12 references

DOIFull text

Open access

Concepts

Abstract

Background and Aims: Patients with chronic hepatitis C (CHC) and end-stage renal disease (ESRD) who are dialysis-dependent form a unique group, in which safety, tolerability and efficacy of sofosbuvir (SOF)-based direct-acting antivirals (DAAs) need further evaluation.

References

12